TAS 102 mechanism of action compared to 5-FU
Por um escritor misterioso
Descrição
Efficacy of trifluridine and tipiracil (TAS-102) versus placebo
Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against
Redefining Later-Line Therapy in Metastatic Colorectal Cancer - EMJ
Mechanism of acquired 5FU resistance and strategy for overcoming
Mode of action of TAS-114S. S-1(TS-1), an orally available fixed
Review of 5-FU resistance mechanisms in colorectal cancer
Review of 5-FU resistance mechanisms in colorectal cancer
Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against
Metastatic colorectal cancer: Advances in the folate
Therapeutic potential of TAS-102 in the treatment of
TAS-102 plus bevacizumab for patients with metastatic colorectal
de
por adulto (o preço varia de acordo com o tamanho do grupo)
